Jason Brown

Assistant Professor

University Hospital

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jason Brown is an Assistant Professor at University Hospitals in the United States. His research focuses on the treatment and management of genitourinary cancers, particularly urothelial carcinoma and prostate cancer. Recent publications include studies on gene expression signatures, resistance to novel therapies, and the assessment of circulating tumor DNA in cancer patients.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (6)

Oliver Sartor

Tulane University School of Medicine

UNITED STATES

View details

Pedro Barata

Associate Professor of Medicine

University Hospitals Seidman Cancer Center

UNITED STATES

View details

Huihui Fan

Assistant Professor

The University of Texas Health Science Center at Houston John P and Katherine G McGovern Medical School

UNITED STATES

View details

Robert Dess

University of Michigan

UNITED STATES

View details

Aristotelis Bamias

GREECE

View details

Neeraj Agarwal

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jason Brown

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Cross-Comparison Individual Patient-Level Analysis of Three Gene Expression Signatures in Localized Prostate in Over 50,000 Men

Strategies to overcome resistance to enfortumab vedotin and pembrolizumab for patients with urothelial carcinoma: harnessing present knowledge for future advances

Targeting HER2 in metastatic urothelial carcinoma: a contemporary review

Circulating Tumor DNA To Assess Minimal Residual Disease: Versatile, but How Valuable?

Identification and Validation of Prognostic Model for Tumor Microenvironment-Associated Genes in Bladder Cancer Based on Single-Cell RNA Sequencing Data Sets

Systematic review of recent advancements in antibody-drug and bicycle toxin conjugates for the treatment of urothelial cancer

Avelumab First-Line Maintenance for Locally Advanced or Metastatic Urothelial Carcinoma: Results From the Real-World US PATRIOT-II Study

Longitudinal Monitoring of Circulating Tumor DNA to Assess the Efficacy of Immune Checkpoint Inhibitors in Patients With Advanced Genitourinary Malignancies

Lutetium-177 PSMA for the treatment of metastatic castrate resistant prostate cancer: a systematic review

Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): “Real World” Experience

Systematic Review of Treatment of Metastatic Non-Clear Cell Renal Cell Carcinoma

Outlook into the future of front-line immune checkpoint inhibition in metastatic urothelial carcinoma

The Potential of Circular RNAs as Cancer Biomarkers.

Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancer

Collaborators (6)

Oliver Sartor

Pedro Barata

Huihui Fan

Robert Dess

Aristotelis Bamias

Neeraj Agarwal

Make your next move.